Your browser doesn't support javascript.
loading
Salvage cystectomy and ileal conduit urinary diversion as a last-line option for benign diseases-perioperative safety and postoperative health-related quality of life.
Volz, Yannic; Eismann, Lennert; Pfitzinger, Paulo L; Jokisch, Jan-Friedrich; Schulz, Gerald; Rodler, Severin; Buchner, Alexander; Schlenker, Boris; Stief, Christian G; Kretschmer, Alexander.
Afiliación
  • Volz Y; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Eismann L; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Pfitzinger PL; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Jokisch JF; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Schulz G; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Rodler S; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Buchner A; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Schlenker B; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Stief CG; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
  • Kretschmer A; Department of Urology, Ludwig-Maximilians University, Munich, Germany.
Neurourol Urodyn ; 40(5): 1154-1164, 2021 06.
Article en En | MEDLINE | ID: mdl-33939196
AIMS: Radical cystectomy and urinary diversion impact various dimensions of patients' health-related-quality-of-life (HRQOL). Yet, less is known about salvage cystectomy as a last-line option for treatment-refractory benign diseases. Therefore, our aim is to provide HRQOL data from a contemporary cohort of open salvage cystectomies for benign conditions. METHODS: Fifty-four consecutive patients were enrolled in one single tertiary referral center. Analysis was limited to patients undergoing urinary diversion via ileal conduit (IC). Complications were assessed via Clavien-Dindo-scale. HRQOL was measured using the validated European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-BLM30 questionnaire. HRQOL QLQ-C30 domains were measured preoperatively and up to 3 years postoperatively. Longitudinal changes were analyzed using Friedman's rank test. Primary endpoint was good general HRQOL based on QLQ-C30 global health status (GHS). Multivariate analysis was performed using logistic regression models with a step-wise backward selection procedure. RESULTS: Longitudinal analysis of HRQOL subdomains revealed significantly improved pain (p = .005) and fatigue (p = .002) scores as well as improved social functioning (p = .038). Furthermore, general HRQOL (GHS scores) improved significantly during the follow-up period (28.0 vs. 50.6 [36 months], p = .045). In multivariate analysis, the indication for salvage cystectomy could not be identified as an independent predictor for good general HRQOL. We observed a total number of 10 (41.7%) high-grade (Clavien ≥III) 90 day-complications. Limitations include limited follow-up rates at respective time-points. CONCLUSION: Salvage cystectomy and IC can be safely performed as a last-line treatment for benign conditions and increases general HRQOL in the long-term follow-up. Thus, it can play a role in a holistic approach for a challenging clinical setting.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derivación Urinaria Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Neurourol Urodyn Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Derivación Urinaria Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Neurourol Urodyn Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos